Should You Stay Away From HEXO Stock?

HEXO (TSX:HEXO)(NASDAQ:HEXO) stock is on a downward spiral, and there is little hope it is going to recover soon.

| More on:

HEXO (TSX:HEXO)(NASDAQ:HEXO) is one of the largest licensed cannabis companies in Canada. It’s okay to be bullish on the Canadian cannabis industry, but HEXO stock is not for cautious investors.

The promise of wealth in the marijuana market was fully realized just a few years ago. But after this came the COVID-19 pandemic, supply chain issues, and the disappointing rollout of Cannabis 2.0 (edibles, vapes, etc.). Among the cannabis stocks hardest hit during the decline of the cannabis industry was HEXO, a once-promising competitor in the market.

HEXO shares, valued at around $7 a year ago, can’t even stay above $1 lately. Not so long ago, the stock hovered around $0.26.

Meanwhile, HEXO’s market capitalization fell below $100 million.

Delisting may be a possibility, as the Nasdaq stock exchange has occasionally issued delisting warnings when stocks trade below $1 for an extended period.

HEXO reports huge losses

Meanwhile, HEXO’s financial results are in shambles. During the company’s last quarter, Hexo suffered a net loss of approximately $146.6 million. That figure was around $21 million a year earlier.

The cannabis producer said third-quarter revenue rose 101% to $45.6 million from a year earlier but fell by 14% compared to the previous quarter in a context of continued competition in the Canadian market.

HEXO reported adjusted EBITDA of $18.4 million — a sharp decline from the $10.8 million loss reported in the prior-year quarter.

Clearly, HEXO is not on the right fiscal path. We can ask ourselves if the company is doing what it takes to get out of this financial misery.

To help answer this crucial question, we can check out what HEXO has been up to lately.

HEXO said its restructuring plan to streamline its structure and cut costs included cutting 450 jobs.

In financial documents, the Quebec company indicated that this staff reduction would result in annual savings of $30.6 million and aims to simplify its organizational structure so that costs are more closely aligned with the business’s size.

The company’s latest management discussion and analysis document indicates that most of the reductions will be achieved with less reliance on external consultants, a new information technology platform, and synergies discovered through recent acquisitions.

HEXO will close a processing and manufacturing facility in Belleville, Ontario by the end of July.

Unfortunately, approximately 230 employees will lose their jobs at this factory.

So, what else did HEXO do? Of course, the company is launching a stock market program that will allow HEXO to issue and sell up to $40 million (or the equivalent in Canadian currency) of stock. The obvious concern here is stock dilution.

What to do with HEXO stock

Overall, HEXO is in dire financial straits, and issuing stock is unlikely to be an effective long-term solution. Ultimately, HEXO will have to prove its viability as a business. The road to recovery, if it actually happens, will not be easy.

As HEXO stock could continue its incessant fall, potential investors should simply avoid it altogether and look for a better risk/reward profile elsewhere.

Fool contributor Stephanie Bedard-Chateauneuf owns shares of HEXO Corp. The Motley Fool recommends HEXO Corp.

More on Cannabis Stocks

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Canopy Growth Stock Jumped 30% Last Month: What’s Going on?

Canopy Growth (TSX:WEED) stock is picking up traction again, making it an enticing weed play to buy on strength.

Read more »

A cannabis plant grows.
Cannabis Stocks

These Threats Facing Canopy Growth Stock Could Justify Selling it

Let's dive into whether Canopy Growth (TSX:WEED) is a top stock investors should buy right now after its recent dip…

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

This BioCannabis Firm Could Explode with Product Approval

This cannabis stock used to be a major name, so where does it stand now?

Read more »

Medicinal research is conducted on cannabis.
Stocks for Beginners

This TSX Health-Care Stock Is a Long-Term Buy for Patient Investors

This TSX stock continues to be one of the best long-term opportunities, if you're patient.

Read more »